ArticleCureus2025
Usual Interstitial Pneumonia and Lung Cancer.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background Lung cancer is the leading cause of cancer-related mortality worldwide, with a notable association between interstitial lung diseases, particularly usual interstitial pneumonia (UIP), and lung cancer. This study investigates the epidemiology, clinical characteristics, histological findings, and treatment implications of this relationship. Methodology A retrospective study was conducted at the Department of Pneumology of Hassan II University Hospital in Fez, Morocco, from January 2016 to September 2024. Patient records of those with established UIP/idiopathic pulmonary fibrosis who developed lung cancer during follow-up, as well as lung cancer patients discussed in thoracic oncology multidisciplinary meetings with UIP pattern identified on CT, were reviewed. Data on demographics, clinical presentation, radiological and histological findings, treatment, and outcomes were collected and analyzed using Epi Info version 7.2.6.0. Results In total, 10 male patients with UIP and lung cancer were included, with a mean age of 66.2 years. Cough 8 (80%) and dyspnea 7 (70%) were the most common symptoms. Radiologically, 7 (70%) had definite UIP, and tumors were predominantly located in the lower lobes. Histological analysis revealed an equal distribution of adenocarcinoma and squamous carcinoma at four (40%) each, with six (60%) patients diagnosed at stage IV. Treatment varied, with one patient undergoing surgery, while others received chemotherapy or radiotherapy. Unfortunately, four patients died, highlighting the aggressive nature of the disease. Conclusions The association between UIP and lung cancer presents significant clinical challenges, impacting treatment strategies and survival outcomes. Continued research is vital to developing effective management protocols. A multidisciplinary approach is essential to optimize care for patients facing the dual burden of UIP and lung cancer, ultimately aiming to improve their prognosis and quality of life.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.